Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma

Colon carcinomas comprise over two-thirds of all colorectal cancers with an overall 5-year survival rate of 64%, which rapidly decreases to 14% when the cancer becomes metastatic. Depending on the stage of colon carcinoma at diagnosis, patients can undergo surgery to attempt complete tumor resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheetz, Lindsay M., Yu, Minzhi, Li, Dan, Castro, María G., Moon, James J., Schwendeman, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084365/
https://www.ncbi.nlm.nih.gov/pubmed/32150841
http://dx.doi.org/10.3390/ijms21051777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084365/
https://www.ncbi.nlm.nih.gov/pubmed/32150841
http://dx.doi.org/10.3390/ijms21051777

Ejemplares similares